Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin gamma 1 pseudogene 15 (ACTG1P15) is a human genomic locus annotated as a pseudogene, meaning it is similar in sequence to ACTG1 (the protein-coding gene for gamma-actin), but does not encode a functional protein. Pseudogenes like ACTG1P15 are often genomic remnants that have lost their protein-coding potential due to mutations. ACTG1P15 has no experimentally supported biological function, disease association, or therapeutic relevance. To summarize, ACTG1P15 is not a therapeutic target, receptor, enzyme, transporter, or transcription factor. It is simply a pseudogene with no current attributed molecular or disease role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin gamma 1 pseudogene 15 (ACTG1P15).